Related Experiment Video

Updated: Jun 24, 2026

Rapid Generation of Amyloid from Native Proteins In vitro
05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

Divergent toxicity mechanisms of amyloid-beta aggregates arising from a single aggregation reaction

Vanya Metodieva1, Sybille Marchese1, Pietro Esposito1

  • 1School of Biology, University of St Andrews, St Andrews, UK.

Cell Reports
|June 22, 2026
PubMed

Insights

Distinct amyloid-β 42 (Aβ42) aggregate species drive Alzheimer's disease (AD) pathology differently. Early aggregates impair neuronal function, while later ones activate microglia, causing synaptic damage and severe neuronal disruption.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Amyloid-β 1-42 (Aβ42) aggregation is a key early event in Alzheimer's disease (AD) pathogenesis.
  • Understanding the distinct toxicities of different Aβ42 aggregate species is crucial for developing effective AD therapies.

Purpose of the Study:

  • To characterize Aβ42 species at various aggregation stages at the single-molecule level.
  • To examine the differential toxicity of these Aβ42 species in a relevant biological model.

Main Methods:

  • Single-molecule characterization of Aβ42 aggregates.
  • Toxicity assessment in murine organotypic brain slices.
  • Analysis of neuronal activity, microglial states, and molecular pathways.

Main Results:

  • Lag phase Aβ42 aggregates increased neuronal Ca2+ and impaired long-term potentiation (LTP), promoting microglial transition to disease-associated microglia (DAM).
  • Growth phase Aβ42 aggregates induced TLR4-mediated microglial activation, cytokine release, and complement activation, leading to synaptic loss and neuronal dysfunction.
  • Structurally distinct Aβ42 aggregates activate different cellular and molecular pathways.

Conclusions:

  • Aβ42 aggregate species exhibit stage-dependent toxicity, differentially impacting neuronal and microglial function in Alzheimer's disease.
  • This study provides a framework for understanding amyloid toxicity and designing combination therapeutic strategies for AD.
Keywords:
Alzheimer’s diseaseCP: molecular biologyCP: neuroscienceDAMTAK-242TLR4amyloid-betacalcium imaginginflammationmicrogliaorganotypic hippocampal slicessingle-molecule imaging

More Related Videos

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...